Anika Therapeutics, Inc. Accrued Liabilities, Current
Anika Therapeutics, Inc. (ANIK) had Accrued Liabilities, Current of $7.96 million as of 2018-03-31, per its 10-Q filed 2018-05-10.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2018-05-10
- 2018-03-31: Accrued Liabilities, Current $7.96M.
- 2017-12-31: Accrued Liabilities, Current $6.33M.
- 2017-09-30: Accrued Liabilities, Current $6.52M.
- 2017-06-30: Accrued Liabilities, Current $5.67M.
| Period end | Accrued Liabilities, Current | Accrued Liabilities, Current as first filed |
|---|---|---|
| 2018-03-31 | $7.96M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $6.33M 10-Q · filed 2018-05-10 | |
| 2017-09-30 | $6.52M 10-Q · filed 2017-10-27 | |
| 2017-06-30 | $5.67M 10-Q · filed 2017-07-28 | |
| 2016-12-31 | $6.50M 10-K · filed 2018-02-27 | |
| 2016-09-30 | $5.42M 10-Q · filed 2016-11-01 | |
| 2016-06-30 | $6.64M 10-Q · filed 2016-08-01 | |
| 2016-03-31 | $6.00M 10-Q · filed 2016-05-03 | |
| 2015-12-31 | $6.50M 10-Q · filed 2017-05-04 | $4.78M 10-K · filed 2016-03-10 |
| 2015-09-30 | $6.55M 10-Q · filed 2015-11-03 | |
| 2015-06-30 | $4.44M 10-Q · filed 2015-08-04 | |
| 2015-03-31 | $4.24M 10-Q · filed 2015-05-04 | |
| 2014-12-31 | $4.77M 10-K · filed 2016-03-10 | $4.75M 10-K · filed 2015-03-13 |
| 2014-09-30 | $5.25M 10-Q · filed 2014-11-06 | |
| 2014-06-30 | $4.88M 10-Q · filed 2014-08-04 | |
| 2014-03-31 | $4.50M 10-Q · filed 2014-05-05 | |
| 2013-12-31 | $5.54M 10-K · filed 2015-03-13 | |
| 2013-09-30 | $5.23M 10-Q · filed 2013-11-05 | |
| 2013-06-30 | $4.50M 10-Q · filed 2013-08-06 | |
| 2013-03-31 | $4.25M 10-Q · filed 2013-05-06 | |
| 2012-12-31 | $5.84M 10-K · filed 2014-03-13 | |
| 2012-09-30 | $4.39M 10-Q · filed 2012-11-08 | |
| 2012-06-30 | $4.28M 10-Q · filed 2012-08-07 | |
| 2012-03-31 | $4.30M 10-Q · filed 2012-05-07 | |
| 2011-12-31 | $5.32M 10-K · filed 2013-03-14 | |
| 2011-09-30 | $5.54M 10-Q · filed 2011-11-04 | |
| 2011-06-30 | $5.49M 10-Q/A · filed 2011-08-10 | |
| 2010-12-31 | $5.38M 10-K · filed 2012-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |